Health FDA approved lung cancer drug created by Mirati to cost $19,750 for 180 tablets by Editor December 13, 2022 by Editor December 13, 2022 The US Food and Drug Administration has approved Mirati Therapeutics Inc’s lung cancer drug Adagrasib, according to the company, sending shares of the… Read more 0 FacebookTwitterPinterestEmail
